In this study, conducted in a Danish clinical database for rheumatological patients and a large German health insurance database, we observed a trend towards a lower risk of dementia among patients treated with tumor necrosis factor-α inhibitors versus patients treated with other anti-inflammatory drugs.

Further clinical trials and cohort studies are needed to clarify the potential of tumor necrosis factor-α inhibitors for the prevention of incident dementia or its progression.